文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Multicentre evaluation of magnetic technology for localisation of non-palpable breast lesions and targeted axillary nodes.

作者信息

McCamley Chere, Ruyssers Natacha, To Henry, Tsao Simon, Keane Holly, Poliness Cathie, Mehta Kirti, Rose Allison, Baker Caroline, Mann Gregory B

机构信息

Department of Breast Surgery, Royal Women's Hospital, Melbourne, Victoria, Australia.

Department of Breast Surgery, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.

出版信息

ANZ J Surg. 2021 Nov;91(11):2411-2417. doi: 10.1111/ans.17108. Epub 2021 Aug 17.


DOI:10.1111/ans.17108
PMID:34405514
Abstract

BACKGROUND: Magseed technology is a recently introduced localisation technique for impalpable breast lesions with possible advantages over traditional techniques. These include improved theatre logistics, flexibility in incision placement and improved patient experience. This multicentre study evaluates the experience of introducing Magseed technology into routine surgical practice. METHODS: A prospective multicentre study of Magseed localised procedures was performed. Insertion data were recorded by the radiologist including lesion characteristics and Magseed insertion accuracy. The surgical team recorded time from insertion to operation, operating time and surgical satisfaction. Pathology results were reviewed for specimen weight and margins. RESULTS: Between February 2019 and June 2020, 100 patients were enrolled. Magseed localised procedures included 18 excisional biopsies, 23 wide local excisions (WLE), 50 WLE with axillary surgery and four cases of Magseed localised breast WLE with Magseed localised axillary surgery. There were three therapeutic mammoplasties and two cases of Magseed localised targeted axillary node dissection alone. A total of 90% of Magseeds were radiologically placed within 5 mm of the target lesion/node. Time between incision and specimen removal was 17 min (range 6-40 min). All breast and axillary Magseeds were successfully identified and retrieved during surgery. The target lesion was identified in the specimen in all cases. A total of 10% of cases required further surgery for pathologically positive margins. Overall, surgeons reported that Magseed localisation was "easy" or "very easy" in 77% of cases. CONCLUSION: Magseed is a reliable, safe and accurate surgical technique that provides logistical advantages and flexibility of surgical approach. The method was well-accepted by all users.

摘要

相似文献

[1]
Multicentre evaluation of magnetic technology for localisation of non-palpable breast lesions and targeted axillary nodes.

ANZ J Surg. 2021-11

[2]
Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions.

Breast Cancer. 2021-1

[3]
A prospective, single-arm, multicentre clinical evaluation of a new localisation technique using non-radioactive Magseeds for surgery of clinically occult breast lesions.

Clin Radiol. 2019-9-25

[4]
Magnetic Seed (Magseed) Localisation in Breast Cancer Surgery: A Multicentre Clinical Trial.

Breast Care (Basel). 2021-8

[5]
Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study.

Eur J Surg Oncol. 2019-6-26

[6]
Wireless localisation of breast lesions with MagSeed. A radiological perspective of 300 cases.

Br J Radiol. 2022-5-1

[7]
Results of shared learning of a new magnetic seed localisation device - A UK iBRA-NET breast cancer localisation study.

Eur J Surg Oncol. 2022-12

[8]
An Audit on Oncological Safety with Magseed Localised Breast Conserving Surgery.

Indian J Surg Oncol. 2022-9

[9]
Introducing SentiMag in a rural setting: a 5-year experience.

ANZ J Surg. 2021-11

[10]
Magnetic Seed Localization (Magseed) for excision of impalpable breast lesions-The North Wales experience.

Breast J. 2021-6

引用本文的文献

[1]
Reliability of Magseed® marking before neoadjuvant systemic therapy with subsequent contrast-enhanced mammography in patients with non-palpable breast cancer lesions after treatment: the MAGMA study.

Breast Cancer Res Treat. 2024-11

[2]
Surgical marker navigation system in breast conserving surgery and excision of non-palpable lesions: first Spanish single-center experience.

Breast Cancer Res Treat. 2024-10

[3]
Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study.

Breast Cancer Res Treat. 2023-12

[4]
Clinical experience of the Magseed magnetic marker to localize non-palpable breast lesions: a cohort study of 100 consecutive cases.

Gland Surg. 2023-5-30

[5]
Wireless localisation of breast lesions with MagSeed. A radiological perspective of 300 cases.

Br J Radiol. 2022-5-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索